<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2007-06-26" modified="2020-10-07" version="162">
<accession>O43294</accession>
<accession>B2R8D5</accession>
<accession>Q9BPW3</accession>
<accession>Q9Y2V5</accession>
<name>TGFI1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transforming growth factor beta-1-induced transcript 1 protein</fullName>
</recommendedName>
<alternativeName>
<fullName>Androgen receptor coactivator 55 kDa protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Androgen receptor-associated protein of 55 kDa</fullName>
</alternativeName>
<alternativeName>
<fullName>Hydrogen peroxide-inducible clone 5 protein</fullName>
<shortName>Hic-5</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TGFB1I1</name>
<name type="synonym">ARA55</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="8316" last="8321">
<title>Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate.</title>
<authorList>
<person name="Fujimoto N."/>
<person name="Yeh S."/>
<person name="Kang H.-Y."/>
<person name="Inui S."/>
<person name="Chang H.-C."/>
<person name="Mizokami A."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="10075738"/>
<dbReference type="DOI" id="10.1074/jbc.274.12.8316"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AR</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2005-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT HIS-129</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-461 (ISOFORM 1)</scope>
<source>
<tissue>Muscle</tissue>
<tissue>Ovary</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="1003" last="1014">
<title>Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions.</title>
<authorList>
<person name="Matsuya M."/>
<person name="Sasaki H."/>
<person name="Aoto H."/>
<person name="Mitaka T."/>
<person name="Nagura K."/>
<person name="Ohba T."/>
<person name="Ishino M."/>
<person name="Takahashi S."/>
<person name="Suzuki R."/>
<person name="Sasaki T."/>
</authorList>
<dbReference type="PubMed" id="9422762"/>
<dbReference type="DOI" id="10.1074/jbc.273.2.1003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 2-461 (ISOFORM 1)</scope>
<scope>INTERACTION WITH PTK2/FAK1 AND PTK2B/PYK2</scope>
<source>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="1224" last="1235">
<title>Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts.</title>
<authorList>
<person name="Shibanuma M."/>
<person name="Mochizuki E."/>
<person name="Maniwa R."/>
<person name="Mashimo J.I."/>
<person name="Nishiya N."/>
<person name="Imai S."/>
<person name="Takano T."/>
<person name="Oshimura M."/>
<person name="Nose K."/>
</authorList>
<dbReference type="PubMed" id="9032249"/>
<dbReference type="DOI" id="10.1128/mcb.17.3.1224"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="26516" last="26521">
<title>Interaction of Hic-5, A senescence-related protein, with focal adhesion kinase.</title>
<authorList>
<person name="Fujita H."/>
<person name="Kamiguchi K."/>
<person name="Cho D."/>
<person name="Shibanuma M."/>
<person name="Morimoto C."/>
<person name="Tachibana K."/>
</authorList>
<dbReference type="PubMed" id="9756887"/>
<dbReference type="DOI" id="10.1074/jbc.273.41.26516"/>
</citation>
<scope>INTERACTION WITH PTK2/FAK1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="J. Cell Sci." volume="111" first="2181" last="2188">
<title>Recruitment of the LIM protein hic-5 to focal contacts of human platelets.</title>
<authorList>
<person name="Hagmann J."/>
<person name="Grob M."/>
<person name="Welman A."/>
<person name="van Willigen G."/>
<person name="Burger M.M."/>
</authorList>
<dbReference type="PubMed" id="9664039"/>
</citation>
<scope>INTERACTION WITH PTK2/FAK1 AND TALIN</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="FEBS Lett." volume="474" first="179" last="183">
<title>Phosphorylation of Hic-5 at tyrosine 60 by CAKbeta and Fyn.</title>
<authorList>
<person name="Ishino M."/>
<person name="Aoto H."/>
<person name="Sasaski H."/>
<person name="Suzuki R."/>
<person name="Sasaki T."/>
</authorList>
<dbReference type="PubMed" id="10838081"/>
<dbReference type="DOI" id="10.1016/s0014-5793(00)01597-0"/>
</citation>
<scope>MUTAGENESIS OF TYR-60</scope>
<scope>PHOSPHORYLATION AT TYR-60</scope>
<scope>INTERACTION WITH CSK AND PTK2B/PYK2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Mol. Carcinog." volume="27" first="177" last="183">
<title>Molecular cloning of human Hic-5, a potential regulator involved in signal transduction and cellular senescence.</title>
<authorList>
<person name="Zhang J."/>
<person name="Zhang L.-X."/>
<person name="Meltzer P.S."/>
<person name="Barrett J.C."/>
<person name="Trent J.M."/>
</authorList>
<dbReference type="PubMed" id="10708479"/>
<dbReference type="DOI" id="10.1002/(sici)1098-2744(200003)27:3&lt;177::aid-mc4&gt;3.0.co;2-s"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Biochem. J." volume="355" first="691" last="697">
<title>Involvement of Hic-5 in platelet activation: integrin alphaIIbbeta3-dependent tyrosine phosphorylation and association with proline-rich tyrosine kinase 2.</title>
<authorList>
<person name="Osada M."/>
<person name="Ohmori T."/>
<person name="Yatomi Y."/>
<person name="Satoh K."/>
<person name="Hosogaya S."/>
<person name="Ozaki Y."/>
</authorList>
<dbReference type="PubMed" id="11311131"/>
<dbReference type="DOI" id="10.1042/bj3550691"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PTK2B/PYK2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2001" name="Blood" volume="97" first="2633" last="2639">
<title>CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk.</title>
<authorList>
<person name="Oda A."/>
<person name="Ochs H.D."/>
<person name="Lasky L.A."/>
<person name="Spencer S."/>
<person name="Ozaki K."/>
<person name="Fujihara M."/>
<person name="Handa M."/>
<person name="Ikebuchi K."/>
<person name="Ikeda H."/>
</authorList>
<dbReference type="PubMed" id="11313252"/>
<dbReference type="DOI" id="10.1182/blood.v97.9.2633"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="J. Dermatol. Sci." volume="27" first="147" last="151">
<title>Potential anti-androgenic activity of roxithromycin in skin.</title>
<authorList>
<person name="Inui S."/>
<person name="Nakajima T."/>
<person name="Fukuzato Y."/>
<person name="Fujimoto N."/>
<person name="Chang C."/>
<person name="Yoshikawa K."/>
<person name="Itami S."/>
</authorList>
<dbReference type="PubMed" id="11532379"/>
<dbReference type="DOI" id="10.1016/s0923-1811(01)00129-3"/>
</citation>
<scope>INDUCTION BY HYDROGEN PEROXIDE</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="5332" last="5345">
<title>Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase.</title>
<authorList>
<person name="Nishiya N."/>
<person name="Tachibana K."/>
<person name="Shibanuma M."/>
<person name="Mashimo J.I."/>
<person name="Nose K."/>
</authorList>
<dbReference type="PubMed" id="11463817"/>
<dbReference type="DOI" id="10.1128/mcb.21.16.5332-5345.2001"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="Urology" volume="58" first="289" last="294">
<title>Different expression of androgen receptor coactivators in human prostate.</title>
<authorList>
<person name="Fujimoto N."/>
<person name="Mizokami A."/>
<person name="Harada S."/>
<person name="Matsumoto T."/>
</authorList>
<dbReference type="PubMed" id="11489729"/>
<dbReference type="DOI" id="10.1016/s0090-4295(01)01117-7"/>
</citation>
<scope>INDUCTION BY TNF</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="299" first="360" last="365">
<title>Transcriptional activation of the c-fos gene by a LIM protein, Hic-5.</title>
<authorList>
<person name="Kim-Kaneyama J.-R."/>
<person name="Shibanuma M."/>
<person name="Nose K."/>
</authorList>
<dbReference type="PubMed" id="12445807"/>
<dbReference type="DOI" id="10.1016/s0006-291x(02)02644-x"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="J. Biochem." volume="132" first="279" last="289">
<title>Hic-5 interacts with GIT1 with a different binding mode from paxillin.</title>
<authorList>
<person name="Nishiya N."/>
<person name="Shirai T."/>
<person name="Suzuki W."/>
<person name="Nose K."/>
</authorList>
<dbReference type="PubMed" id="12153727"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a003222"/>
</citation>
<scope>INTERACTION WITH GIT1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="15426" last="15431">
<title>Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator.</title>
<authorList>
<person name="Wang X."/>
<person name="Yang Y."/>
<person name="Guo X."/>
<person name="Sampson E.R."/>
<person name="Hsu C.-L."/>
<person name="Tsai M.-Y."/>
<person name="Yeh S."/>
<person name="Wu G."/>
<person name="Guo Y."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="11856738"/>
<dbReference type="DOI" id="10.1074/jbc.m111218200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PTK2B/PYK2</scope>
<scope>PHOSPHORYLATION AT TYR-60 BY FAK2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="J. Neurosci." volume="22" first="7045" last="7054">
<title>The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter.</title>
<authorList>
<person name="Carneiro A.M.D."/>
<person name="Ingram S.L."/>
<person name="Beaulieu J.-M."/>
<person name="Sweeney A."/>
<person name="Amara S.G."/>
<person name="Thomas S.M."/>
<person name="Caron M.G."/>
<person name="Torres G.E."/>
</authorList>
<dbReference type="PubMed" id="12177201"/>
<dbReference type="DOI" id="10.1523/jneurosci.22-16-07045.2002"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SLC6A3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="23691" last="23698">
<title>The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs.</title>
<authorList>
<person name="Hsu C.-L."/>
<person name="Chen Y.-L."/>
<person name="Yeh S."/>
<person name="Ting H.-J."/>
<person name="Hu Y.-C."/>
<person name="Lin H."/>
<person name="Wang X."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="12714604"/>
<dbReference type="DOI" id="10.1074/jbc.m211908200"/>
</citation>
<scope>INTERACTION WITH AR</scope>
<scope>MUTAGENESIS OF 338-PHE--PHE-342 AND 456-PHE--PHE-460</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="J. Histochem. Cytochem." volume="51" first="513" last="521">
<title>Expression of the LIM proteins paxillin and Hic-5 in human tissues.</title>
<authorList>
<person name="Yuminamochi T."/>
<person name="Yatomi Y."/>
<person name="Osada M."/>
<person name="Ohmori T."/>
<person name="Ishii Y."/>
<person name="Nakazawa K."/>
<person name="Hosogaya S."/>
<person name="Ozaki Y."/>
</authorList>
<dbReference type="PubMed" id="12642630"/>
<dbReference type="DOI" id="10.1177/002215540305100413"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Mol. Biol. Cell" volume="14" first="1158" last="1171">
<title>Hic-5 communicates between focal adhesions and the nucleus through oxidant-sensitive nuclear export signal.</title>
<authorList>
<person name="Shibanuma M."/>
<person name="Kim-Kaneyama J.-R."/>
<person name="Ishino K."/>
<person name="Sakamoto N."/>
<person name="Hishiki T."/>
<person name="Yamaguchi K."/>
<person name="Mori K."/>
<person name="Mashimo J.I."/>
<person name="Nose K."/>
</authorList>
<dbReference type="PubMed" id="12631731"/>
<dbReference type="DOI" id="10.1091/mbc.02-06-0099"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="5124" last="5129">
<title>Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells.</title>
<authorList>
<person name="Rahman M.M."/>
<person name="Miyamoto H."/>
<person name="Lardy H."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="12700349"/>
<dbReference type="DOI" id="10.1073/pnas.0530097100"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="Prostate" volume="56" first="192" last="200">
<title>Expression of androgen receptor coactivators in normal and cancer prostate tissues and cultured cell lines.</title>
<authorList>
<person name="Mestayer C."/>
<person name="Blanchere M."/>
<person name="Jaubert F."/>
<person name="Dufour B."/>
<person name="Mowszowicz I."/>
</authorList>
<dbReference type="PubMed" id="12772188"/>
<dbReference type="DOI" id="10.1002/pros.10229"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="J. Cell. Biochem." volume="92" first="810" last="819">
<title>Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation.</title>
<authorList>
<person name="Guerrero-Santoro J."/>
<person name="Yang L."/>
<person name="Stallcup M.R."/>
<person name="DeFranco D.B."/>
</authorList>
<dbReference type="PubMed" id="15211577"/>
<dbReference type="DOI" id="10.1002/jcb.20109"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NR3C1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="Genes Dev." volume="19" first="362" last="375">
<title>Hic-5 regulates an epithelial program mediated by PPARgamma.</title>
<authorList>
<person name="Drori S."/>
<person name="Girnun G.D."/>
<person name="Tou L."/>
<person name="Szwaya J.D."/>
<person name="Mueller E."/>
<person name="Xia K."/>
<person name="Shivdasani R.A."/>
<person name="Spiegelman B.M."/>
</authorList>
<dbReference type="PubMed" id="15687259"/>
<dbReference type="DOI" id="10.1101/gad.1240705"/>
</citation>
<scope>INTERACTION WITH PPARG</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="5154" last="5162">
<title>Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling.</title>
<authorList>
<person name="Wang H."/>
<person name="Song K."/>
<person name="Sponseller T.L."/>
<person name="Danielpour D."/>
</authorList>
<dbReference type="PubMed" id="15561701"/>
<dbReference type="DOI" id="10.1074/jbc.m411575200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SMAD3</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="171" first="893" last="904">
<title>Subcellular targeting of oxidants during endothelial cell migration.</title>
<authorList>
<person name="Wu R.F."/>
<person name="Xu Y.C."/>
<person name="Ma Z."/>
<person name="Nwariaku F.E."/>
<person name="Sarosi G.A. Jr."/>
<person name="Terada L.S."/>
</authorList>
<dbReference type="PubMed" id="16330715"/>
<dbReference type="DOI" id="10.1083/jcb.200507004"/>
</citation>
<scope>INTERACTION WITH TRAF4</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="7326" last="7333">
<title>Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.</title>
<authorList>
<person name="Heitzer M.D."/>
<person name="DeFranco D.B."/>
</authorList>
<dbReference type="PubMed" id="16849583"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-2379"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="16821" last="16832">
<title>ERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5.</title>
<authorList>
<person name="Saelzler M.P."/>
<person name="Spackman C.C."/>
<person name="Liu Y."/>
<person name="Martinez L.C."/>
<person name="Harris J.P."/>
<person name="Abe M.K."/>
</authorList>
<dbReference type="PubMed" id="16624805"/>
<dbReference type="DOI" id="10.1074/jbc.m512418200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAPK15</scope>
<scope>MUTAGENESIS OF CYS-369; CYS-372; HIS-428 AND CYS-431</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="24769" last="24780">
<title>Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter.</title>
<authorList>
<person name="Carneiro A.M.D."/>
<person name="Blakely R.D."/>
</authorList>
<dbReference type="PubMed" id="16803896"/>
<dbReference type="DOI" id="10.1074/jbc.m603877200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SLC6A4</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Mol. Endocrinol." volume="20" first="56" last="64">
<title>Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator.</title>
<authorList>
<person name="Heitzer M.D."/>
<person name="DeFranco D.B."/>
</authorList>
<dbReference type="PubMed" id="16141357"/>
<dbReference type="DOI" id="10.1210/me.2005-0065"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="Neuroendocrinology" volume="84" first="285" last="300">
<title>Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5.</title>
<authorList>
<person name="Maudsley S."/>
<person name="Davidson L."/>
<person name="Pawson A.J."/>
<person name="Freestone S.H."/>
<person name="Lopez de Maturana R."/>
<person name="Thomson A.A."/>
<person name="Millar R.P."/>
</authorList>
<dbReference type="PubMed" id="17202804"/>
<dbReference type="DOI" id="10.1159/000098402"/>
</citation>
<scope>INTERACTION WITH AR; PTK2B/PYK2 AND SRC</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Biochem. J." volume="403" first="275" last="281">
<title>Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets.</title>
<authorList>
<person name="Rathore V.B."/>
<person name="Okada M."/>
<person name="Newman P.J."/>
<person name="Newman D.K."/>
</authorList>
<dbReference type="PubMed" id="17233630"/>
<dbReference type="DOI" id="10.1042/bj20061618"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH CSK AND LYN</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Steroids" volume="72" first="218" last="220">
<title>Hic-5/ARA55 a prostate stroma-specific AR coactivator.</title>
<authorList>
<person name="Heitzer M.D."/>
<person name="DeFranco D.B."/>
</authorList>
<dbReference type="PubMed" id="17166536"/>
<dbReference type="DOI" id="10.1016/j.steroids.2006.11.010"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-137</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E49428" last="E49428">
<title>Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5.</title>
<authorList>
<person name="Ryan P.E."/>
<person name="Kales S.C."/>
<person name="Yadavalli R."/>
<person name="Nau M.M."/>
<person name="Zhang H."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="23145173"/>
<dbReference type="DOI" id="10.1371/journal.pone.0049428"/>
</citation>
<scope>INTERACTION WITH CBLC</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF CYS-287 AND CYS-313</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-137; SER-141; SER-164; SER-192 AND SER-194</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33; SER-68; SER-137; SER-140; SER-143; SER-192; SER-403 AND THR-407</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text evidence="10 14 17 19 20 22 25 26 28 30 31 32 33 35 37">Functions as a molecular adapter coordinating multiple protein-protein interactions at the focal adhesion complex and in the nucleus. Links various intracellular signaling modules to plasma membrane receptors and regulates the Wnt and TGFB signaling pathways. May also regulate SLC6A3 and SLC6A4 targeting to the plasma membrane hence regulating their activity. In the nucleus, functions as a nuclear receptor coactivator regulating glucocorticoid, androgen, mineralocorticoid and progesterone receptor transcriptional activity. May play a role in the processes of cell growth, proliferation, migration, differentiation and senescence. May have a zinc-dependent DNA-binding activity.</text>
</comment>
<comment type="subunit">
<text evidence="10 12 13 17 18 19 22 23 25 26 27 29 30 31 34 35 36 38 39 40">Homooligomer. Interacts with CRIP2, HSPB1, ILK, LIMS1, LIMS2, NCK2, NUDT16L1, PAK, PPARG, PTPN12, TCF3, TCF7L2 and VCL. Forms a complex with GIT1 and ARHGEF7. Interacts with AR/androgen receptor in a ligand-dependent manner. Interacts with CSK, LYN, MAPK15, NR3C1, PPARG, PTK2/FAK1, PTK2B/PYK2, SLC6A3, SLC6A4, SMAD3, SRC and talin. Interacts (via LIM zinc-binding domain 2) with CBLC (via RING-type zinc finger); the interaction is direct and enhances CBLC E3 ubiquitin-protein ligase activity.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1051449">
<id>O43294</id>
</interactant>
<interactant intactId="EBI-703044">
<id>P13612</id>
<label>ITGA4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1051449">
<id>O43294</id>
</interactant>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1051449">
<id>O43294</id>
</interactant>
<interactant intactId="EBI-3650647">
<id>Q9BUZ4</id>
<label>TRAF4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1051449">
<id>O43294</id>
</interactant>
<interactant intactId="EBI-2849869">
<id>O68743</id>
<label>YPMT1.25Ac</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell junction</location>
<location>Focal adhesion</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus matrix</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
</subcellularLocation>
<text>Associated with the actin cytoskeleton; colocalizes with stress fibers.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O43294-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O43294-2</id>
<name>2</name>
<sequence type="described" ref="VSP_026183"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="10 11 13 21 24 32 33 35 39">Expressed in platelets, smooth muscle and prostate stromal cells (at protein level).</text>
</comment>
<comment type="induction">
<text evidence="15 16">Up-regulated by TNF and hydrogen peroxide.</text>
</comment>
<comment type="domain">
<text>The LIM zinc-binding domains mediate glucocorticoid receptor coactivation and interaction with AR, CRIP2, ILK, LIMS1, NR3C1, PPARG, TCF3, TCF7L2, SLC6A3 and SMAD3. The LIM zinc-binding 2 and LIM zinc-binding 3 domains mediate targeting to focal adhesions and actin stress fibers. The LIM zinc-binding 3 and LIM zinc-binding 4 domains mediate interaction with TRAF4 and MAPK15. The LIM zinc-binding 4 domain mediates interaction with HSPB1, homooligomerization and targeting to the nuclear matrix. The LIM zinc-binding 3 domain mediates interaction with PTPN12.</text>
</comment>
<comment type="domain">
<text>The LD (leucine and aspartate-rich) motif 3 mediates interaction with GIT1 and functions as a nuclear export signal.</text>
</comment>
<comment type="PTM">
<text evidence="12 13 17 34 35">Phosphorylated by gonadotropin-releasing hormone-activated SRC.</text>
</comment>
<comment type="similarity">
<text evidence="45">Belongs to the paxillin family.</text>
</comment>
<comment type="sequence caution" evidence="45">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH32545" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/tgfb1i1/"/>
</comment>
<dbReference type="EMBL" id="AF116343">
<property type="protein sequence ID" value="AAD22552.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ309025">
<property type="protein sequence ID" value="ABB96286.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313327">
<property type="protein sequence ID" value="BAG36132.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471192">
<property type="protein sequence ID" value="EAW52126.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001507">
<property type="protein sequence ID" value="AAH01507.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001830">
<property type="protein sequence ID" value="AAH01830.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017288">
<property type="protein sequence ID" value="AAH17288.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032545">
<property type="protein sequence ID" value="AAH32545.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB007836">
<property type="protein sequence ID" value="BAA24799.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10713.1">
<molecule id="O43294-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42156.1">
<molecule id="O43294-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001035919.1">
<molecule id="O43294-1"/>
<property type="nucleotide sequence ID" value="NM_001042454.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001158191.1">
<molecule id="O43294-2"/>
<property type="nucleotide sequence ID" value="NM_001164719.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_057011.2">
<molecule id="O43294-2"/>
<property type="nucleotide sequence ID" value="NM_015927.4"/>
</dbReference>
<dbReference type="SMR" id="O43294"/>
<dbReference type="BioGRID" id="112899">
<property type="interactions" value="35"/>
</dbReference>
<dbReference type="DIP" id="DIP-5931N"/>
<dbReference type="ELM" id="O43294"/>
<dbReference type="IntAct" id="O43294">
<property type="interactions" value="31"/>
</dbReference>
<dbReference type="MINT" id="O43294"/>
<dbReference type="STRING" id="9606.ENSP00000378332"/>
<dbReference type="iPTMnet" id="O43294"/>
<dbReference type="MetOSite" id="O43294"/>
<dbReference type="PhosphoSitePlus" id="O43294"/>
<dbReference type="BioMuta" id="TGFB1I1"/>
<dbReference type="EPD" id="O43294"/>
<dbReference type="jPOST" id="O43294"/>
<dbReference type="MassIVE" id="O43294"/>
<dbReference type="MaxQB" id="O43294"/>
<dbReference type="PaxDb" id="O43294"/>
<dbReference type="PeptideAtlas" id="O43294"/>
<dbReference type="PRIDE" id="O43294"/>
<dbReference type="ProteomicsDB" id="48865">
<molecule id="O43294-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48866">
<molecule id="O43294-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="1738">
<property type="antibodies" value="235 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7041"/>
<dbReference type="Ensembl" id="ENST00000361773">
<molecule id="O43294-2"/>
<property type="protein sequence ID" value="ENSP00000355117"/>
<property type="gene ID" value="ENSG00000140682"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394858">
<molecule id="O43294-2"/>
<property type="protein sequence ID" value="ENSP00000378327"/>
<property type="gene ID" value="ENSG00000140682"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394863">
<molecule id="O43294-1"/>
<property type="protein sequence ID" value="ENSP00000378332"/>
<property type="gene ID" value="ENSG00000140682"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000567607">
<molecule id="O43294-2"/>
<property type="protein sequence ID" value="ENSP00000457586"/>
<property type="gene ID" value="ENSG00000140682"/>
</dbReference>
<dbReference type="GeneID" id="7041"/>
<dbReference type="KEGG" id="hsa:7041"/>
<dbReference type="UCSC" id="uc002ecd.3">
<molecule id="O43294-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7041"/>
<dbReference type="DisGeNET" id="7041"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000140682.18"/>
<dbReference type="GeneCards" id="TGFB1I1"/>
<dbReference type="HGNC" id="HGNC:11767">
<property type="gene designation" value="TGFB1I1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000140682">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="602353">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O43294"/>
<dbReference type="OpenTargets" id="ENSG00000140682"/>
<dbReference type="PharmGKB" id="PA36481"/>
<dbReference type="eggNOG" id="KOG1703">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160447"/>
<dbReference type="HOGENOM" id="CLU_001357_1_2_1"/>
<dbReference type="InParanoid" id="O43294"/>
<dbReference type="OMA" id="PEHFICG"/>
<dbReference type="OrthoDB" id="1593918at2759"/>
<dbReference type="PhylomeDB" id="O43294"/>
<dbReference type="TreeFam" id="TF314113"/>
<dbReference type="PathwayCommons" id="O43294"/>
<dbReference type="SignaLink" id="O43294"/>
<dbReference type="BioGRID-ORCS" id="7041">
<property type="hits" value="84 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TGFB1I1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="TGFB1I1"/>
<dbReference type="GenomeRNAi" id="7041"/>
<dbReference type="Pharos" id="O43294">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O43294"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="RNAct" id="O43294">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000140682">
<property type="expression patterns" value="Expressed in myometrium and 213 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O43294">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O43294">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050681">
<property type="term" value="F:androgen receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070411">
<property type="term" value="F:I-SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048495">
<property type="term" value="F:Roundabout binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003712">
<property type="term" value="F:transcription coregulator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045165">
<property type="term" value="P:cell fate commitment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030855">
<property type="term" value="P:epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016331">
<property type="term" value="P:morphogenesis of embryonic epithelium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045599">
<property type="term" value="P:negative regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030512">
<property type="term" value="P:negative regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010718">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030511">
<property type="term" value="P:positive regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009408">
<property type="term" value="P:response to heat"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030579">
<property type="term" value="P:ubiquitin-dependent SMAD protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR017305">
<property type="entry name" value="Tgfb1i1/Leupaxin/TGFB1I1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001781">
<property type="entry name" value="Znf_LIM"/>
</dbReference>
<dbReference type="Pfam" id="PF00412">
<property type="entry name" value="LIM"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037881">
<property type="entry name" value="Leupaxin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00132">
<property type="entry name" value="LIM"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS00478">
<property type="entry name" value="LIM_DOMAIN_1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50023">
<property type="entry name" value="LIM_DOMAIN_2"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0440">LIM domain</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Transforming growth factor beta-1-induced transcript 1 protein" id="PRO_0000291582">
<location>
<begin position="1"/>
<end position="461"/>
</location>
</feature>
<feature type="domain" description="LIM zinc-binding 1" evidence="9">
<location>
<begin position="226"/>
<end position="285"/>
</location>
</feature>
<feature type="domain" description="LIM zinc-binding 2" evidence="9">
<location>
<begin position="286"/>
<end position="343"/>
</location>
</feature>
<feature type="domain" description="LIM zinc-binding 3" evidence="9">
<location>
<begin position="344"/>
<end position="403"/>
</location>
</feature>
<feature type="domain" description="LIM zinc-binding 4" evidence="9">
<location>
<begin position="404"/>
<end position="461"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PTK2B/PYK2">
<location>
<begin position="1"/>
<end position="240"/>
</location>
</feature>
<feature type="region of interest" description="Transcription activation" evidence="7">
<location>
<begin position="1"/>
<end position="200"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PTK2/FAK1" evidence="7">
<location>
<begin position="83"/>
<end position="136"/>
</location>
</feature>
<feature type="short sequence motif" description="LD motif 1">
<location>
<begin position="3"/>
<end position="15"/>
</location>
</feature>
<feature type="short sequence motif" description="LD motif 2">
<location>
<begin position="92"/>
<end position="104"/>
</location>
</feature>
<feature type="short sequence motif" description="LD motif 3">
<location>
<begin position="157"/>
<end position="168"/>
</location>
</feature>
<feature type="short sequence motif" description="LD motif 4">
<location>
<begin position="203"/>
<end position="215"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="4">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2 6">
<location>
<position position="33"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="8">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FAK2 and FYN" evidence="12 17">
<location>
<position position="60"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 6">
<location>
<position position="68"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 6">
<location>
<position position="137"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="140"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="141"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="143"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="164"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="186"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="188"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6">
<location>
<position position="192"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="194"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="403"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="407"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_026183" evidence="42 43 44">
<location>
<begin position="1"/>
<end position="17"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45475699." id="VAR_032831" evidence="41">
<original>Q</original>
<variation>H</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents phosphorylation by FAK2 and FYN. Prevents interaction with CSK." evidence="12">
<original>Y</original>
<variation>F</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CBLC and enhancement of CBLC E3 ubiquitin-protein ligase activity." evidence="36">
<original>C</original>
<variation>A</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with CBLC." evidence="36">
<original>C</original>
<variation>A</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with AR; when associated with 456-A--A-460." evidence="23">
<original>FLQLF</original>
<variation>ALQAA</variation>
<location>
<begin position="338"/>
<end position="342"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of AR coactivation; when associated with S-372." evidence="30">
<original>C</original>
<variation>S</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of AR coactivation; when associated with S-369." evidence="30">
<original>C</original>
<variation>S</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of AR coactivation; when associated with S-431." evidence="30">
<original>H</original>
<variation>S</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of AR coactivation; when associated with S-428." evidence="30">
<original>C</original>
<variation>S</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with AR; when associated with 338-A--A-342." evidence="23">
<original>FLKLF</original>
<variation>ALKAA</variation>
<location>
<begin position="456"/>
<end position="460"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD22552." ref="1" evidence="45">
<original>S</original>
<variation>P</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD22552." ref="1" evidence="45">
<original>G</original>
<variation>A</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD22552." ref="1" evidence="45">
<original>A</original>
<variation>L</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD22552." ref="1" evidence="45">
<original>CA</original>
<variation>WP</variation>
<location>
<begin position="405"/>
<end position="406"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD22552." ref="1" evidence="45">
<original>T</original>
<variation>A</variation>
<location>
<position position="430"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62219"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00125"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10075738"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10708479"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10838081"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11311131"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11463817"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11489729"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11532379"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11856738"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12153727"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12177201"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12445807"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12642630"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12700349"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12714604"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12772188"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15211577"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15561701"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15687259"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16141357"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16330715"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16624805"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16803896"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16849583"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17166536"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17202804"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17233630"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23145173"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9032249"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9422762"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9664039"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9756887"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source ref="2"/>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10075738"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000305"/>
<sequence length="461" mass="49814" checksum="D2C7C32C3FD2C496" modified="2007-06-26" version="2">MEDLDALLSDLETTTSHMPRSGAPKERPAEPLTPPPSYGHQPQTGSGESSGASGDKDHLYSTVCKPRSPKPAAPAAPPFSSSSGVLGTGLCELDRLLQELNATQFNITDEIMSQFPSSKVASGEQKEDQSEDKKRPSLPSSPSPGLPKASATSATLELDRLMASLSDFRVQNHLPASGPTQPPVVSSTNEGSPSPPEPTGKGSLDTMLGLLQSDLSRRGVPTQAKGLCGSCNKPIAGQVVTALGRAWHPEHFVCGGCSTALGGSSFFEKDGAPFCPECYFERFSPRCGFCNQPIRHKMVTALGTHWHPEHFCCVSCGEPFGDEGFHEREGRPYCRRDFLQLFAPRCQGCQGPILDNYISALSALWHPDCFVCRECFAPFSGGSFFEHEGRPLCENHFHARRGSLCATCGLPVTGRCVSALGRRFHPDHFTCTFCLRPLTKGSFQERAGKPYCQPCFLKLFG</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

